60 DEGREES PHARMACEUTICALS, INC. — Form 8-K
Filed September 14, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 12/100
What the filing says
60 Degrees Pharmaceuticals filed a Form 8-K on 2026-09-14 reporting other events for the period ended 2026-09-12. The filing document itself contains no substantive disclosure text—only metadata, XBRL formatting files, and administrative details. The actual content of Item 8.01 is not provided in this filing excerpt.
Why this rating
No material event details disclosed; filing is administrative boilerplate. Cannot assess impact without substance of Item 8.01 disclosure.
Extracted items
See more from September 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.